Dundee Corp T.DC.A

Alternate Symbol(s): DDEJF

Healthcare Metals & Mining Technology Gold Industrial Metals & Minerals Silver

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee Sustainable Technologies Inc. (Dundee Technologies), Dundee Resources Limited, and Goodman & Company, Investment Counsel Inc. The Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. Through the development of its patented processes, the GlassLock Process and the CLEVR Process, Dundee Technologies extracts precious and base metals from ores and concentrates, while stabilizing contaminants such as arsenic.

TSX:DC.A - Post by User

Dundee Corp > New Press Release - Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million

<< Previous

Bullboard Posts

Next >>

Comment by pierrelebelon Sep 27, 2024 10:41am

77 Views

Post# 36243991

RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million

The announcement stinks as the announcement of this relatively small transaction makes no sense.

Could it be that management, before closing the third quarter on Monday, wants to substantially increase the "value" of its holdings in TauRx?

If so, for what purpose?

If management really want to proceed with thier concept of Dundee 2.0 (mining exploration/production), TauRx does not belong in it.

Either sell it if you can find a buyer for one million shares or transfer TauRx into a new unit and give it to shareholders (about one share of TauRx for every 90 shares of DC.A held).

Those who have confidence TauRx will succeed could keep it and increase their position buying from those who are not convinced on the merits of TauRx and would cash in their shares.

Everybody would get exactly what they want.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity